ロード中...
Temozolomide-associated hypermutation in gliomas
Low-grade gliomas cause considerable morbidity and most will recur after initial therapy. At recurrence, low-grade gliomas can undergo transformation to high-grade gliomas (grade III or grade IV), which are associated with worse prognosis. Temozolomide (TMZ) provides survival benefit in patients wit...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120358/ https://ncbi.nlm.nih.gov/pubmed/29452419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|